QualiTRuST: Understanding the factors that enable and hinder the adoption and use of new tools for the treatment and elimination of P. vivax malaria in Brazil

Objectives

To understand the factors that enable and hinder the adoption and use of new tools (including single-dose tafenoquine and point-of-care G6PD testing) for the treatment and elimination of P. vivax malaria in the health system and in communities affected by the disease in Manaus and Porto Velho, Brazil.